RA patients receiving anti-inflammatory treatments have overall reduced risk of developing AD, and peripheral neutralization of TNF-α, a key cytokine driving RA pathogenesis, was shown effective in AD animal models [159]. The gene discussed is TNF; the disease is rheumatoid arthritis.